BioNTech SE is 15.3x more valuable than Immunocore Holdings plc by market capitalization ($21.79 B vs $1.43 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | IMCR | BNTX |
|---|---|---|
| Market cap | $1.43 B | $21.79 B |
| US-listed rank | #2369 | #587 |
| Revenue (latest FY) | $400.02M | - |
| Net income (latest FY) | -$35.51M | - |
| Net margin | -8.9% | - |
| SEC filings | 265 | 548 |
BioNTech SE is 15.3x more valuable than Immunocore Holdings plc by market capitalization ($21.79 B vs $1.43 B).
Full pages: Immunocore Holdings plc and BioNTech SE, or browse the full rankings.